The QualityStocks Daily Tuesday, May 5th, 2020

Today's Top 3 Investment Newsletters

QualityStocks (SBFM) +168.75%

StockMarketWatch (PTLA) +130.03%

OTCtipReporter (CLSK) +124.26%

The QualityStocks Daily Stock List

American Manganese, Inc. (AMYZF)

Stockwatch, Pink Investing, Proactive Investors, The Prospector News, Streetwise Reports, Investing News, Market Screener, Stockaholics, Wallet Investor, InvestorsHub, OTC.Watch, Morningstar, GuruFocus, Resource World, Metals News, Market Trend News, Stocktube, GlobeNewswire, Market Wire News, Stockhouse, and TradingView reported previously on American Manganese, Inc. (AMYZF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

American Manganese, Inc. is a critical metals company listed on the OTC Markets. It focuses on the recycling of lithium-ion batteries with the RecycLiCo™ Patented Process. The Company’s goal is to commercialize its pioneering RecycLiCo™ Patented Process and become an industry leader in recycling cathode materials from spent lithium-ion batteries.

Incorporated in 1987, American Manganese is headquartered in Surrey, British Columbia. The Company previously went by the name Rocher Deboule Minerals Corporation. It changed its corporate name to American Manganese, Inc. in January of 2010.

The RecycLiCo™ Patented Process provides high extraction of cathode metals. These include lithium, cobalt, nickel, manganese, and aluminum at battery grade purity, with minimal processing steps. Key benefits include a circular recycling process (consumer battery waste sourced from urban areas and processed for reuse in lithium-ion batteries).

Key benefits also include being environmentally friendly, being economically strong (low cost recovery process with minimal processing steps and known resource content in feedstock), and legislation worldwide is highly supportive of recycling and mineral recovery from urban waste.

In early April, American Manganese reported independent analytical results from its contract lab, Kemetco Research. Using American Manganese's patented RecycLiCo™ process, Kemetco conducted recycling tests on lithium-ion battery cathode material and produced a nickel-cobalt sulfate product at 99.99% purity. Kemetco Research is a private sector integrated science, technology and innovation enterprise.

Recently, American Manganese reported the signing of a Memorandum of Understanding (MOU) with Voltabox of Texas, Inc. a subsidiary of Voltabox AG, outlining a proposed business relationship between American Manganese and Voltabox to provide end-of-life lithium-ion batteries for commercial-scale recycling of cathode materials using American Manganese's RecycLiCo™ patented process.

Last week, American Manganese announced that its contractor, Kemetco Research, has developed a conceptual layout for American Manganese's initial commercial lithium-ion battery cathode recycling plant with a 3 tonne per day processing capacity. From Kemetco Research's analysis and experience with comparative projects, the capital expense is estimated to be US$ 12 million accounting for the design and construction of specialized equipment.

American Manganese looks to upgrade capacity of the pilot plant project and continue testing sample lithium-ion battery material received from battery manufacturers to collaborate with proprietary cathode formulas that could attain optimal material recovery, including purity, particle distribution, and particle size, with minimal environmental impact.

American Manganese, Inc. (AMYZF), closed Tuesday's trading session at $0.102, up 2.00%, on 152,119 volume with 98 trades. The average volume for the last 3 months is 131,546 and the stock's 52-week low/high is $0.067299999/$0.237000003.

chart

Future Farm Technologies, Inc. (FFRMF)

Zacks, Investors Hangout, MarketWatch, Investing Daily, Daily Marijuana Observer, OTC Markets, Barchart, Morningstar, GuruFocus, OTC.Watch, Proactive Investors, Dividend Investor, TradingView, Infront Analytics, Marijuana Stocks, TipRanks, MarketBeat, GlobeNewswire, CannabisFN, Macroaxis, Nasdaq, Wallet Investor, NIC Investors, InvestorsHub, Seeking Alpha, Stockhouse, Stockwatch, and Dividend.com reported beforehand on Future Farm Technologies, Inc. (FFRMF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Future Farm Technologies, Inc. is positioned to be a top supplier of hemp-derived CBD (cannabidiol) products to meet the growing demand in the U.S. and global markets. The Company’s experienced management team has a deep understanding of operations and agriculture with the financial and regulatory expertise needed to become an industry leader in the changing market for CBD and related compounds. The Company formerly went by the name Arcturus Growthstar Technologies, Inc. It changed its name to Future Farm Technologies, Inc. in February of 2017. OTCQB-listed, Future Farm Technologies has offices in Vancouver, British Columbia, and Dedham, Massachusetts.

Future Farm current key initiatives are the cultivation and processing of its hemp crop growing in Maine, the pursuit of other hemp-related opportunities across the U.S., and the development of elite strains of cannabis in Canada. In October 2019, Future Farm Technologies announced that hemp from its farm in Hersey, Maine passed the State-mandated testing for acceptable (i.e. below 0.3 percent) levels of THC (Tetrahydrocannabinol). The Company harvested its hemp in October and completed the drying and curing phase of the biomass for extraction and seeds. Both crops attained yields that outpaced the Company’s apparatus for seed extraction, plant bucking, processing and storage.

Future Farm Technologies continues to pursue licenses to grow cannabis for sale, research and development in Canada. It has discontinued projects related to marijuana in the USA to enhance its access to capital and simplify other facets of business operations, including banking and tax planning.

Future Farm owns a completely operational greenhouse business on roughly 10-acres in Apopka, Florida known as White Sand Nursery. At present, White Sand grows ornamental plants that sell in large retail stores across North America. In response to the recent passage of the 2018 U.S. Farm Bill, Future Farm decided to expand its existing hemp portfolio to include a partnership in Florida.

The core of Future Farm Technologies’ breeding and genetics operation are in its relationship with CEPG Consulting and Design, Inc. (CEPG). CEPG is an experienced developer of controlled environment plant growth systems located in St. John’s, Newfoundland.

Today, Future Farm Technologies announced relief efforts for farmers planning their 2020 hemp farms. The Company announced that it has developed a two-tier approach to address market concerns during this difficult time and to provide much needed options for farmers in planning their 2020 season.

First, Future Farm has developed relationships with leading breeders to deliver feminized seeds of top cultivars, if desired. Second, the Company announced relief-based pricing for its high CBD producing Cherry Wine hemp seeds. When farmers purchase 1,000 “regular” (i.e. non-feminized) seeds for $50.00, Future Farm will include an additional 2,000 seeds.

Future Farm Technologies, Inc. (FFRMF), closed Tuesday's trading session at $0.019, off by 13.242%, on 57,964 volume with 28 trades. The average volume for the last 3 months is 169,717 and the stock's 52-week low/high is $0.012099999/$0.120999999.

chart
n

Kraig Biocraft Laboratories, Inc. (KBLB)

SynBioBeta, Market Screener, The OTC Reporter, Stock Pulse, GuruFocus, Investor Village, TipRanks, Simply Wall St, Infront Analytics, hot Stocked, Discovery Stocks, Stockwatch, InvestorsHub, Insider Financial, Emerging Growth, Stockhouse, Trading View, Wallet Investor, and Super Stock Screener reported beforehand on Kraig Biocraft Laboratories, Inc. (KBLB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Kraig Biocraft Laboratories, Inc. is the foremost developer of genetically engineered spider silk based fibers. The Company has attained a series of scientific breakthroughs in the area of spider silk technology with implications for the worldwide textile industry. Its genetic engineering research has succeeded in developing what many consider to be the holy grail of material science – a practical and cost-effective technology for producing recombinant spider silk based fibers on an industrial scale. Kraig Biocraft Laboratories is headquartered in Ann Arbor, Michigan. The Company lists on the OTCQB.

Kraig Biocraft obtained at its inception, proprietary genetic engineering technology to unlock the mystery of producing spider silk. In early 2006, it obtained certain exclusive rights from the University of Wyoming to use the spider silk gene sequences in its field of use. Spider silk holds the potential of a lifesaving ballistic resistant material - lighter, thinner, flexible and tougher than steel material. It is among the strongest fibers produced in nature. Some spider species can produce up to seven different types of silk depending upon the spider’s specific need at that time.

The Company has its Monster Silk™ and Dragon Silk™ for commercialization. Kraig Biocraft is also continuing to develop new and recombinant spider silk fibers. It has created the next generation of recombinant spider silk using its new design, gene editing, as well as incorporation approaches. It designed this approach to customize mechanical properties for specific commercial markets. Kraig Biocraft has demonstrated the ability to more speedily, accurately, and efficiently produce new transgenics.

Last month, Kraig Biocraft Laboratories announced that it successfully developed a new technology platform, based on a non-CRISPR gene editing knock-in knock-out technology. Other than the silkworm’s remaining specifically desired native silk protein elements, the Company is now able to produce almost pure spider silk.

This new technology has a purity rate that is approximately ten times greater than Dragon Silk, a fiber that Kraig Biocraft developed with its previous tools. The new system employs the Company’s eco-friendly and cost effective silkworm production system.

Kraig Biocraft Laboratories, Inc. (KBLB), closed Tuesday's trading session at $0.1551, off by 1.2102%, on 1,186,441 volume with 140 trades. The average volume for the last 3 months is 2,868,896 and the stock's 52-week low/high is $0.090000003/$0.507000029.

chart

Painted Pony Energy Ltd. (PDPYF)

Zacks, YCharts, GuruFocus, Macrotrends, Morningstar, Street Insider, SmarterAnalyst, Analyst Ratings, Dividend Investor, News Quantified, TradingView, Simply Wall St, Dividend.com, Investor Welcome, Wallmine, Market Screener, Stockhouse, Wallet Investor, Nasdaq, Ceo.ca, Investing News, and GlobeNewswire reported on Painted Pony Energy Ltd. (PDPYF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Painted Pony Energy Ltd. is a natural gas company mainly focused on the development of natural gas and natural gas liquids from the Montney formation in northeast British Columbia. Its corporate philosophy is to grow by way of production development drilling for natural gas and natural gas liquids. Its mission is to establish the Company as a low-cost supplier of clean natural gas to Canada and the world. The Company previously went by the name Painted Pony Petroleum Ltd. It changed its name to Painted Pony Energy Ltd. in May of 2017. Listed on the OTC Markets, Painted Pony Energy has its head office in Calgary, Alberta.

The Company’s strategic goal is to provide shareholders with an impressive and consistent per share growth profile of production, reserves, and cash flow via the development of its premium, sweet natural gas resource base located in the optimum area. Painted Pony Energy’s Montney gas is sweet gas with high heat content and no associated water production. The Montney is one of North America’s premier natural gas resource plays. It is larger in scope and with similar potential as the Marcellus play of the northeastern U.S.

Painted Pony Energy’s 2019 Average Daily Production was 294 MMcfe/d (48,979 boe/d). The Company’s 2019 2P Reserve Life Index is 64 Years. Painted Pony’s First Half 2020 Capital Budget is $25-30 million. The Company’s Enterprise Value is $370 million. Painted Pony Energy’s program for 2020 includes drilling 10 gross (4 net) wells and completing 2 gross (2 net) wells.

This past March, Painted Pony Energy announced Q4 and Full-Year 2019 financial and operating results, year-end 2019 reserves, 2020 first-half capital spending, and anticipated future reductions to transportation, processing, and general and administrative expenses (G&A). Selected highlights include drilling starting in March 2020 on an eight-well Montney program by joint venture (JV) partner and project operator Tourmaline Oil Corp. on the 25 percent working interest (WI) South Townsend block. Painted Pony delivered a 2019 Proved Developed Producing (PDP) recycle ratio of 1.3 times, resulting in a three-year average PDP recycle ratio of 1.5 times.

The Company reduced Total Proved (1P) future development capital (FDC) by 11 percent or $172 million. Painted Pony increased production volumes to an estimated daily average of 315 MMcfe/d (53,000 boe/d) for the months December 2019, January 2020, and February 2020, based on actuals and field estimates.

Painted Pony Energy Ltd. (PDPYF), closed Tuesday's trading session at $0.4791, up 4.7671%, on 46,505 volume with 8 trades. The average volume for the last 3 months is 31,056 and the stock's 52-week low/high is $0.137600004/$1.03999996.

chart

PureTech Health plc (PTCHF)

Stock Gumshoe, Wallet Investor, GuruFocus, OTC Markets, Macroaxis, Whale Wisdom, Real Investment Advice, StockInvest.us, Market Screener, YCharts, Dividend Investor, Morningstar, Investors Hangout, Nasdaq, Seeking Alpha, Investors Observer, Stockhouse, Dividend.com, TMXmoney, and Current Charts reported earlier on PureTech Health plc (PTCHF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

PureTech Health plc is a clinical stage biotechnology company based in Boston, Massachusetts. It is discovering, developing and commercializing highly differentiated medicines for devastating diseases. These include intractable cancers, lymphatic and gastrointestinal diseases, central nervous system (CNS) disorders, and inflammatory and immunological diseases, among others. PureTech has created an extensive and deep pipeline through the expertise of its experienced research and development (R&D) team and its broad network of scientists, clinicians, and industry leaders. Incorporated in 2015, PureTech Health lists on the OTC Markets.

PureTech established the underlying programs and platforms that have resulted in a substantial pipeline comprising 23 product candidates and one product cleared by the FDA (Food and Drug Administration). This pipeline is being advanced internally and via PureTech’s Founded Entities. PureTech Health’s emphasis is the Brain-Immune-Gut (BIG) axis. It is developing new categories of therapeutics through leveraging the science of the BIG axis.

The Company’s internal programs are focused on harnessing the lymphatic system and related immunology mechanisms for the treatment of cancer, immunological, lymphatic, and CNS-related disorders. Concerning its ‘affiliate programs’, the affiliates include 13 clinical-stage product candidates, including one product cleared by the FDA and a second product candidate that has been filed with the FDA for review, and several other novel preclinical programs that have been developed in collaboration with some of the world's leading scientific experts.

Recently, PureTech Health announced that the first participant has been dosed in a clinical study of LYT-100, the Company’s wholly-owned product candidate for the potential treatment of lymphedema and other fibrotic conditions. There are presently no FDA-approved drugs to treat lymphedema, which is a painful, progressive, and chronic condition that affects about one million individuals in the United States alone.

The design of the Phase 1, multiple ascending dose and food effect study is to evaluate the safety, tolerability, and pharmacokinetic (PK) profile of LYT-100 in healthy participants. This is a follow-up to the single ascending dose clinical trial of LYT-100 in healthy individuals that was conducted by Auspex. Results from the multiple ascending dose study are expected in 2020. They will enable the initiation of a proof-of-concept study in people with breast cancer-related, upper limb secondary lymphedema later this year.

PureTech Health plc (PTCHF), closed Tuesday's trading session at $3.25, off by 2.9851%, on 1,410 volume with 6 trades. The average volume for the last 3 months is 9,173 and the stock's 52-week low/high is $2.22000002/$4.73999977.

chart

Quarterhill, Inc. (QTRHF)

Zacks, SmarterAnalyst, EquityMood, OTC Markets, Stockhouse, Stocktwits, Stockwatch, Morningstar, GuruFocus, MarketBeat, Business Insider, MarketWatch, Seeking Alpha, Market Screener, Barchart, Dividend Investor, Dividend.com, Macrotrends, TradingView, PR Newswire, Ceo.ca, Investors Hangout, and Wallet Investor reported on Quarterhill, Inc. (QTRHF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A diversified holding company, Quarterhill, Inc. concentrates on the acquisition, management, and growth of companies in dedicated technology areas. This includes vertical market software and solutions, intelligent industrial systems, as well as innovation and licensing. The Company previously went by the name Wi-LAN, Inc. It changed its name to Quarterhill, Inc. in June of 2017. Quarterhill lists on the OTCQX Best Market under the symbol QTRHF and on the TSX under the symbol QTRH. The Company is based in Kitchener, Ontario.

Quarterhill's focus is on seeking out acquisition opportunities at reasonable valuations that provide a basis for recurring revenues, predictable cash flows and margins, profitable growth, intimate customer relationships, and dedicated management teams. Mergers and Acquisitions (M&A) are a key element of the Company’s growth strategy. Quarterhill will look for organic growth in its existing businesses and once acquired, the Company will also look at tuck-in acquisitions that can be part of those same businesses providing incremental revenue and professional growth opportunities.

WiLAN is a wholly-owned subsidiary of Quarterhill centering on patent licensing. WiLAN develops and commercializes inventive patented technologies, manages intellectual property (IP), and licenses these inventions to corporations.

IRD (International Road Dynamics) is a wholly-owned subsidiary of Quarterhill. IRD is a multi-discipline, technology company and a foremost provider of Intelligent Transportation Systems (ITS). IRD’s expertise is integrating ITS technologies into systems designed to solve unique and challenging transportation problems. In addition, VIZIYA is a wholly-owned subsidiary of Quarterhill. VIZIYA is a software and services provider that helps companies optimize their asset performance.

Today, Quarterhill announced the appointment of Mr. Paul Hill as President and Chief Executive Officer of Quarterhill, effective June 1, 2020 . Mr. Hill is an executive with broad experience in managing technology and diversified software companies and in completing acquisitions of technology companies. Mr. Hill will operate out of a Toronto-based Quarterhill office to be established in the near future. Mr. Hill will join Quarterhill's Board of Directors upon starting his employment with Quarterhill.

Quarterhill, Inc. (QTRHF), closed Tuesday's trading session at $1.24, up 2.99%, on 27,037 volume with 45 trades. The average volume for the last 3 months is 16,114 and the stock's 52-week low/high is $0.295049995/$1.59000003.

chart

Sona Nanotech, Inc. (SNANF)

InvestorX, Investing.com, Simply Wall St, Stockhouse, InvestorsHub, Investing News, Dividend Investor, Proactive Investors, Investor Welcome, Stockwatch, Barchart, Seeking Alpha, and Newsfilecorp reported earlier on Sona Nanotech, Inc. (SNANF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A nanotechnology life sciences company, Sona Nanotech, Inc. has developed two proprietary methods for the manufacture of rod-shaped gold nanoparticles. The chief business carried out and intended to be continued by the Company is the development and application of its proprietary technology for use in multiplex diagnostic testing platforms, which it says will improve performance over existing tests in the market. Sona produces high-quality gold nanorod products for diagnostic tests and medical treatment applications. OTCQB-listed, Sona Nanotech has its corporate headquarters in Halifax, Nova Scotia.

The Company states that its innovative gold nanorods will power the next generation of lateral flow diagnostics. Its gold nanorod products feature a highly functionalized and strong manufacturing process and are multicolored and CTAB (cetyltrimethylammonium) free. They also have a long shelf life; functionalized surface properties; typical widths are between 10 and 15 nm; and lengths are from 25-60 nm.

Regarding its Conjugation Service, Sona Nanotech can combine a client’s biologicals with its nanorods to offer a completely optimized conjugate for their assays, lessening their development time. Concerning Lateral Flow Test Development, the Company provides a tailored, modular contract development service from proof of concept through to full development and transfer to production.

Pertaining to Lateral Flow Test Production, Sona Nanotech is partnered with world-class, third-party manufacturers. This is to manufacture pilot and validation batches through to large-scale bulk volumes to serve a client’s market.

Sona’s products include Gemini 650NM, Gemini 700NM, Gemini 750NM, Gemini 800NM, Gemini 850NM, Gemini 900NM, Gemini 950NM, Gemini 1050NM, as well as Omni. Gemini is for Point of Care diagnostics (lateral flow tests, Elisa, electro-chemical biosensors). Omni is for medical applications (drug delivery, photothermal therapy, and cell imaging).

Recently, Sona Nanotech announced that it entered into service and supply agreements with a Contract Manufacturing Organization (CMO) in Europe for the manufacture of its Covid-19 virus-detecting, rapid-response test. In addition, Sona entered into a Letter Of Intent (LOI) agreement with a global distributor representing the health authority of a G20 country for the purchase of 2,000,000 test kits. Sona Nanotech cautions that its test is still in development. However, it expects to complete a functional prototype and confirm third party validation tests in the near future.

Sona has been awarded a $4.1 million grant from NGen, Canada's Advanced Manufacturing Supercluster, to develop and commercialize its Covid-19 rapid-response antigen test. The non-repayable grant will be used to speed up the development of a prototype and scale manufacturing capabilities with a goal to deploying this Covid-19 virus-detecting, Point-of-Care test with Canadian medical authorities as soon as possible.

Sona Nanotech has progressed from feasibility and prototype testing to the optimization stage for its Covid-19 antigen rapid response test. The Company has started work with two, third-party laboratories to prepare validation protocols.

Sona Nanotech, Inc. (SNANF), closed Tuesday's trading session at $1.38, up 10.40%, on 66,291 volume with 59 trades. The average volume for the last 3 months is 62,610 and the stock's 52-week low/high is $0.063885003/$1.90999996.

chart

CleanSpark, Inc. (CLSK)

Financial Buzz, Simply Wall St, YCharts, Insider Financial, Micro Cap Daily, Stockwatch, Uptick Newswire, PR Newswire, Market Screener, Dividend Investor, Stockhouse, MarketWatch, MarketBeat, Equities, GlobeNewswire, Pot Stock News, Insider Tracking, Wallet Investor, Barchart, Trading View, and InvestorsHub reported previously on CleanSpark, Inc. (CLSK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

CleanSpark, Inc. is a microgrid company with advanced engineering, software and controls for unique distributed energy resource (DER) and microgrid deployments. It provides advanced energy software and control technology, which enables a plug-and-play enterprise solution to contemporary energy challenges. The Company's customers include energy consumers and the distributed energy ecosystem at large: developers, installers, EPCs, IPPs, and energy storage vendors. The Company was previously known as Stratean, Inc. It changed its name to CleanSpark, Inc. in November 2016. OTCQB-listed, CleanSpark is based in Utah.

The Company’s services consist of intelligent energy monitoring and controls, microgrid design and engineering, microgrid consulting services, and turn-key microgrid implementation services. CleanSpark’s software enables energy users to obtain resiliency and economic optimization. Its software is innovatively capable of enabling a microgrid to be scaled to the user's specific needs. It can be widely implemented across commercial, industrial, military, agricultural, as well as municipal deployment.

CleanSpark’s Microgrid Value Stream Optimizer outputs are a client’s customized guide to maximizing their energy project’s ROI (Return on Investment). State-of-the-art data analytics account for real costs, precise utility rate models, equipment performance, and actual energy consumption. They outline what kind of energy resources are to be built, what it will cost, and how it will perform upon deployment.

In addition, the Company has its mPulse software - an innovation in controls capable of integrating numerous Distributed Energy Resources (DER). This includes storage, renewables and fossil fuel technologies. CleanSpark’s intelligent software package collects, archives, and analyzes data 24/7 providing real-time control and reporting. Regarding Engineering & Grid Development Services, the Company’s Microgrid Value Stream Optimizer (mVSO) provides critical information. It is also the starting point for CleanSpark’s microgrid development services.

In early December, CleanSpark announced the addition of advanced, multi-year modeling of energy storage equipment to its Microgrid Value Stream Optimizer (mVSO) modeling solution. mVSO’s proprietary microgrid optimization logic has been extended to model detailed vendor specific operating characteristics over full project lifetimes for an array of energy storage solutions. This advanced modeling provides the basis to incorporate specific energy storage solutions across an assortment of industry-leading vendors as equipment options within mVSO.

On December 20, 2019, CleanSpark announced it received $359,000 in new orders in one week for its intelligent switchgear. It's intelligent switchgear is used to automatically transfer power supply from its main source to a backup source when it senses a failure or outage in the primary source, therefore assuring uninterrupted power. In addition, it allows the end user the opportunity to participate in regional energy markets when it makes financial sense to sell surplus power back to the grid.

CleanSpark, Inc. (CLSK), closed Tuesday's trading session at $3.05, up 124.2647%, on 80,320,303 volume. The average volume for the last 3 months is 1,765,482 and the stock's 52-week low/high is $0.970000028/$30.50.

chart

Sunshine Biopharma, Inc. (SBFM)

Stockwatch, Investing.com, Real Investment Advice, Trading View, Market Screener, GuruFocus, Stockopedia, Insider Financial, Simply Wall St, Dividend Investor, Wallet Investor, All Stocks, InvestorsHub and Stockhouse reported earlier on Sunshine Biopharma, Inc. (SBFM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Sunshine Biopharma, Inc. is a pharmaceutical company listed on the OTC Markets. The Company concentrates on the development of drugs for the treatment of aggressive types of cancer. Furthermore, Sunshine offers generic pharmaceuticals, Essential Brand dietary supplements, and certified analytical chemistry services. Sunshine Biopharma has its corporate office in Pointe-Claire, Quebec.

The Company operates by way of three subsidiaries. These comprise Atlas Pharma, Inc. (Testing Services); Sunshine Biopharma Canada, Inc. (Generic Drugs); and NOX Pharmaceuticals, Inc. (Propriety Drugs). Atlas Pharma offers certified testing services of pharmaceutical and other industrial samples. Generic drugs coming soon from Sunshine Biopharma Canada (not available in the U.S.) include SBI-Anastrozole for treatment of Breast Cancer; SBI-Letrozole for treatment of Breast Cancer; SBI-Bicalutamide for treatment of Prostate Cancer; and SBI-Finasteride for treatment of BPH (Benign Prostatic Hyperplasia).

Regarding Sunshine Biopharma’s Proprietary Drugs in development, the Company’s flagship anticancer drug is Adva-27a. This is a GEM-difluorinated C-glycoside derivative of Podophyllotoxin, targeted for different kinds of cancer. The expectation is that Adva-27a will enter Phase I clinical trials for pancreatic cancer and multidrug resistant breast following completion of the GMP manufacturing and formulation of a 2-kilograms quantity for injection.

Sunshine Biopharma also has its dietary supplements product line - Essential 9™. This product contains all 9 essential amino acids in one tablet for maintaining and building muscle mass. In December of 2018, Sunshine Biopharma completed the development of Essential 9™. On December 14, 2018, Health Canada issued NPN 80089663 through which it authorized the Company to manufacture and sell the Essential 9™ product.

In December 2018, Sunshine Biopharma announced it signed an agreement with Crocus Laboratories Inc., (Montreal) for assistance in the manufacturing of Adva-27a. Crocus will help Sunshine Biopharma in the development of a large-scale process for the manufacturing of 2 to 5 kilograms of Adva-27a. The material, which will ultimately be generated by a contract manufacturing organization, will be used for animal toxicity studies and clinical trials.

Recently, Sunshine Biopharma announced it launched 7 new dietary supplements in addition to its original product, Essential 9™. The new products are BCAA; L-Carnitine; L-Creatine; L-Glutamine; Vitaminax; Omega 3; and Vitamin B12.

Sunshine Biopharma, Inc. (SBFM), closed Tuesday's trading session at $0.0043, up 168.75%, on 14,890,412 volume with 328 trades. The average volume for the last 3 months is 18,039,639 and the stock's 52-week low/high is $0.0013/$0.944500029.

chart

HCi Viocare (VICA)

MarketWatch and Financial Times reported previously on HCi Viocare (VICA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.  

HCi Viocare focuses on the development and marketing of prosthetics and orthotics. The Company has a strong pipeline of near-market to research-stage technologies.  HCi Viocare has its executive office in Athens, Greece, and its research and development (R&D) center in Glasgow, Scotland, United Kingdom (UK).  The Company’s shares trade on the OTC Markets’ OTCQB.

HCi Viocare has two fully owned subsidiaries. One is HCi Viocare Technologies. The other is HCi Viocare Clinics. HCi Viocare Technologies is developing hardware solutions aiming to empower the user through providing on demand information and enhancing living quality. 

HCi Viocare’s business model consists of creating the first cross-border independent chain of Prosthetics & Orthotics (P&O) and Diabetic Foot clinics in Europe and the Middle East and developing an extensive portfolio of proprietary hardware solutions with first in line the Flexisense™ sensor system. The clinics will provide independent and personalized quality of care for its patients. The first HCi Viocare clinic has been operating since September 2015 in Glasgow.   

The R&D center is working on a large portfolio of progressive, cutting-edge, and disruptive technologies in the Digital Health, Prosthetics, and Orthotics, Diabetes, Assistive Devices and Sports & Wellbeing fields. HCi Viocare has developed a unique sensing technology with the brand name Flexisense™. 

Flexisense™ technology is the next generation of sensing technologies for wearable devices. Flexisense™ is an inventive sensing technology. It measures pressure and shear forces. In addition, it provides on demand information wirelessly. Flexisense can be incorporated in a wide array of applications.  

The Company has developed a new application for its sensing technology Flexisense™, now for automotive tires. Flexisense™ applied to tires can monitor, in real time, tire deformation and actual traction between the tire and the ground.

HCi Viocare Management, acknowledging the great advantages of Blockchain technology, has decided to develop its own proprietary Blockchain based system for handling the sensitive client records in its Scottish Clinics subsidiary. This team will develop a proprietary Blockchain based system for handling and storing the data produced from the medical applications of its Flexisense™ technology.

In October of 2017, HCi Viocare welcomed Dr. John Doupis, MD, PhD to its team. Dr. Doupis joined the Scientific Advisory Board assuming the role of Director of Clinical Matters and Diabetes. Dr. Doupis is a former Clinical Research Fellow of the Joslin Diabetes Center, Harvard Medical School, in Boston, Massachusetts, and Scientific partner in Beth Israel Deaconess Foot Center Harvard Medical School, Boston, Massachusetts. Dr. Doupis’ special areas of interest are Diabetes and its complications, particularly the Diabetic foot and Obesity.

HCi Viocare (VICA), closed Tuesday's trading session at $0.0976, up 131.829%, on 1,575 volume with 2 trades. The average volume for the last 3 months is 3,165 and the stock's 52-week low/high is $0.009999999/$0.166999995.

chart

Force Protection Video Equipment Corp. (FPVD)

AimHighProfits, Promotion Stock Secrets,  and Insider Financial reported  earlier on Force Protection Video Equipment Corp. (FPVD), and today we highlight the Company, here at the QualityStocks Daily Newsletter. 

Force Protection Video Equipment Corp. (Force Protection)  sells high definition (HD) body camera systems and accessories for law enforcement. The Company offers its LE10 Law Enforcement Video Recorder product. Force Protection has its corporate headquarters in Cary, North Carolina.

The Company previously went by the name Enhancer-Your-Reputation.Com, Inc. It changed its name to Force Protection Video Equipment Corp. in March of 2015. 

Force Protection has incorporated a wholly-owned subsidiary, CobraXtreme HD Corp., a North Carolina Corporation. This subsidiary’s purpose is to sell HD videos sports cameras and accessories that are alike to those sold by GoPro. Furthermore, it will sell video goggles and sunglass cameras.

CobraXtremeHD also carries a complete line of aftermarket accessories for extreme sports cameras such as GoPro® and Garmin®. The design of CobraXtremeHD cameras are for use in extreme sports.

Force Protection has its LE50 HD Bodycam. The LE50 is a state-of-the-art designed body camera. It is strategically built around Ambarella chip sets (AMBA). Select important design features of the LE50 include industry leading record time (10 hours @1080,12 hours @720); 50 hours of standby time; 32GB of internal tamperproof storage; and white LED illumination.

Concerning the Company’s LE10 Law Enforcement Video Recorder product, it is a small bodyworn HD camera. It is half the size and half the price of most law enforcement cameras now on the market. The LE10 has manifold features. These include still picture ability 8MP, WIFI, 4x zoom,  and audio recording. The LE10 does not necessitate special software or costly storage contracts.

In addition, Force Protection released the LE100 and LE101 1080 HD in car video recording dashcam systems. The LE100 and 101 are state-of-the-art designed in-car dash camera systems. They are strategically built around Ambarella A7 chip sets (AMBA). 

The Company also has its camera system for Law Enforcement and Security Agencies. The design of the C1, Citadel camera system is to fight and deter graffiti, illegal dumping, and other property crimes. The self-contained system is solar powered.  The C1 Citadel requires no external power. All of Force Protection’s cameras and recording devices have FCC, IC and CE certification.

Recently, Force Protection announced the release of the RECON 1000 on the body camera. The RECON 1000 incorporates into its design the Ambarella A7 chip to ensure its optimal performance for law enforcement officers. The RECON 1000 is a robust IP67 camera. It is small, lightweight and full of standard features that cameras twice its size and price do not include.

Force Protection announced in May that it received patent pending status from the U.S. Patent and Trademark Office (USPTO) for its proprietary design titled: Shield Harness for Mounting a Camera. The newly designed product will permit law enforcement departments to use existing body worn cameras with their riot shields to collect evidence during protests and disturbances and also to document inmate extraction in prisons. The design will enable the cameras to be mounted securely and have an unobstructed view point of individuals for later identification and for training.

Force Protection Video Equipment Corp. (FPVD), closed Tuesday's trading session at $0.0002, up 100.00%, on 4,772,711 volume with 16 trades. The average volume for the last 3 months is 1,602,208 and the stock's 52-week low/high is $0.000000999/$0.000199999.

chart

China Education Resources, Inc. (CHNUF)

Marketwired, OTC Markets, Barchart, Stockhouse, MarketWatch, Business Insider, Wall Street Reporter, and Stockwatch reported on China Education Resources, Inc. (CHNUF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, China Education Resources, Inc. is an ed-tech company. It has leading technology of intelligent systems and contents to provide online/offline learning, training courses, and social media for teachers, students and education professionals. China Education Resources has its headquarters in Vancouver, British Columbia.

The Company, by way of its subsidiaries in China, is a foremost provider of kindergarten to grade 12 (K-12) education resources and services. This is through its national internet site to China's kindergarten to grade 12 education market.

In addition, the Company has developed soccer education textbooks and a training/learning online platform to provide an innovative blend of online/offline contents and services to teachers and students for soccer education programs. The soccer textbooks include 13 student soccer textbooks (one book per grade) and four teacher’s books for teaching the student soccer textbooks. Additionally, the soccer textbooks have soccer training video contents for students and teachers.

China Education Resources is working on an indoor kids’ soccer training program. The Company has rented a 2,900 square foot space in a shopping mall to commence its indoor kids’ soccer training program. The program will offer face to face soccer training together with the Company’s online soccer training platform with video contents and online/offline interaction among students, coaches and parents.

China Education Resources’ online teacher training program has expanded into another four new provinces in China. The Company was recently selected by the Ministry of Education, China to provide vocational teacher training programs. The vocational online training platform has been developed by China Education Resources together with an initial 185 training courses.

Recently, China Education Resources provided an update on its business development. The Company signed a Memorandum of Understanding (MOU) with World Book, Inc. World Book is part of Berkshire Hathaway and the publisher of the renowned World Book Encyclopedia.

The two parties are discussing cooperation opportunities in certain areas. This includes partnering together to create custom contents around China Education Resources’ programs; distribution of World Book’s books and digital products in English to schools and libraries in China; licensing and translating into Chinese World Book’s titles and selling the books in China; book club with the direct to consumer model, and more.

China Education Resources, Inc. (CHNUF), closed Tuesday's trading session at $0.03, up 130.7692%, on 500 volume with 1 trade. The average volume for the last 3 months is 2,299 and the stock's 52-week low/high is $0.000199999/$0.05.

chart

Foothills Exploration, Inc. (FTXP)

MarketWired, OTC Markets, and InvestorsHub reported on Foothills Exploration, Inc. (FTXP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Foothills Exploration, Inc., through its wholly-owned subsidiary, Foothills Petroleum, Inc. (a Nevada corporation), is an early stage independent oil and gas exploration and production company. It involves in the acquisition and development of oil and gas properties in the Rockies. The Company’s goal is to acquire dislocated and underdeveloped oil and gas assets and maximize those assets. Foothills Exploration is headquartered in Denver, Colorado.

The Company’s strategy is to build a balanced portfolio of E&P assets through concentrating on acquiring producing and developmental properties in the Rockies and focusing on the generation of high-impact oil and gas exploration projects. Foothills Exploration’s goal is to build a land bank of more than 200,000 acres of proven, probable, and prospective reserves.

Currently, Foothills Exploration holds 41,181 acres in the Greater Green River Basin in Wyoming. Its Springs Prospect consists of 38,120 contiguous acres. This is a multiple objective oil resource play in the Greater Green River Basin.

Moreover, the Company has a 35 percent Working Interest (WI) in the Ladysmith Anticline prospect. This prospect is in Fremont County, Wyoming. Ladysmith Anticline in entirety amounts to 3,061 acres. Its location is between the Great Divide/Greater Green River Basin and the Wind River Basin.

Foothills also has its PawPaw Project. The Pawpaw project is a 3-D seismic defined prospect. It covers 4,467 acres and is a direct analog to the highly productive Tensleep Formation “Enigma” Field positioned two miles south.

The Company also has its Ironwood Project. The Ironwood Project is a 6,115-acre up dip field extension play. The adjacent “Cotton Creek” Field produced about 67 million barrels of oil (MMBO) and 68 billion cubic feet of gas (BCFG), chiefly from the Phosphoria Formation.

Foothills Exploration announced in February 2017 that since acquiring Tiger Energy Partners International on December 30, 2016, Foothills has successfully reworked two wells in its Duck Creek project obtaining production from the Green River formation.

Regarding the Duck Creek Area – Natural Buttes Field, Foothills Exploration plans to re-enter two wells in September in the Duck Creek region situated in Uintah County, Utah, in the Natural Buttes field. The Duck Creek wells recently had a third-party engineering report completed. The Report calculated a total PV-10 value of $707,000 of Proved Developed Producing and Proved Developed Non-Producing reserves.

Concerning the Altamont- Bluebell and Brundage Canyon areas, a third-party reserve report was conducted on certain properties, which were acquired via the Tiger Energy Partners International acquisition. According to this Report, the properties have roughly 5.4 million barrels of Proved Undeveloped Reserves. The well depths range from 5,500 feet in the Brundage Canyon area to roughly 18,000 feet in the Altamont-Bluebell area.

Foothills Exploration, Inc. (FTXP), closed Tuesday's trading session at $0.0002, up 100.00%, on 19,055,048 volume with 43 trades. The average volume for the last 3 months is 49,347,082 and the stock's 52-week low/high is $0.000099999/$0.264999985.

chart

eWellness Healthcare Corp. (EWLL)

Penny Stock Prodigy and StockHideout reported earlier on eWellness Healthcare Corp. (EWLL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Culver City, California-based eWellness Healthcare Corp. develops a telemedicine platform. This platform is for providing Distance Monitored Physical Therapy programs. These programs are for pre-diabetic, cardiac, and health challenged patients via contracted physician practices and healthcare systems. The Company has launched PHZIO. The design of this telemedicine platform is to extend and scale a physician’s practice. eWellness Healthcare is the first physical therapy telemedicine enterprise to provide insurance reimbursable real-time distance monitored treatments. eWellness Healthcare lists on the OTC Markets Group’s OTCQB.

The Company’s business model is to license its PHZIO platform to any physical therapy (PT) clinic in the United States and/or have large-scale employers use its PHZIO platform as a completely PT monitored corporate wellness program. eWellness Healthcare’s PHZIO is a Physical Therapy Telemedicine platform. It extends a traditional practice online.

The chief features of the PHZIO platform include video treatment protocols, real-time patient monitoring, patient induction forms, a patient video journal, and post treatment evaluations. In addition, main features include integrated billing, patient metrics, and user administration & customization.

Moreover, PHZIO scales a practice’s billable rates. It also provides tools to make growing a business easier. Pertaining to the Patient Dashboard, the PHZIO Dashboard enables clients to login securely to access prescribed treatment protocols. PHZIO is user-friendly and highly reliable to operate for PT and Patient. Furthermore, it’s a total on-line PT telemedicine intervention system.

eWellness Healthcare has launched a PHZIO PT clinic on-boarding website. The site includes a telehealth profitability calculator to illustrate to prospective PT clinics the additional profits they can make through using the PHZIO platform.

eWellness Healthcare anticipates adding Artificial Intelligence (AI) tools and predictive analytics into its PHZIO platform by the end of this year. The anticipation is that the new AI and predictive analytics will combine the Company’s existing remote monitoring capabilities with machine learning and intelligent analytics, which take advantage of patient health data to improve healthcare outcomes.

Evolution Physical Therapy has added eWellness Healthcare's Telehealth PT Services at its four clinical locations in Los Angeles, California. This includes Culver City, Playa Vista, Beverly Hills, and Brentwood. Mr. Darwin Fogt, Chief Executive Officer of eWellness Healthcare, owns Evolution Physical Therapy.

Recently, eWellness Healthcare and Total Release Physical Therapy announced an Integration & Marketing Agreement. Total Motion Release Seminars (TMR) is a proprietary physical therapy methodology developed by Mr. Tom Dalonzo-Baker, MPT. TMR is a full-body oriented assessment and treatment approach. TMR helps patients lessen their pain and impairments which limit their function. The treatment approach is created to allow physical therapists to interact and treat their patients remotely. The expectation is that integration with PHZIO will be extensively adopted within the TMR community.

eWellness Healthcare Corp. (EWLL), closed Tuesday's trading session at $0.0002, up 100.00%, on 247,559,793 volume with 649 trades. The average volume for the last 3 months is 206,846,876 and the stock's 52-week low/high is $0.000096/$287.50.

chart

The QualityStocks Company Corner

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioScience (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced its plan to change the company’s name to Availa Bio upon completion of the acquisitions and merger of Cannaworx, Inc. and SkinScience Labs, Inc. The three companies will function as synergistic divisions within the combined "Availa Bio" entity, which will focus on optimizing bioavailability, absorption, quality and performance of human, animal and agricultural products. To view the full press releases, visit http://cnw.fm/h2Xht and http://cnw.fm/A1QiO. Also today, the Company was highlighted in a publication from Financialnewsmedia.com, examining how the global nanoemulsions market is forecast to reach USD $16.18 Billion by 2026, according to a new report by Reports and Data. Nanoemulsions have proved to be a novel drug delivery system that allows controlled or sustained release of drug, genetic material, and biologically active ingredient. The interest in the market was developed approximately two decades ago for its nanoparticle preparation, but only recently, was the drug being commercially used in cosmetics and pharmacy.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Tuesday's trading session at $3.70, up 7.2464%, on 37,981 volume with 135 trades. The average volume for the last 3 months is 11,237 and the stock's 52-week low/high is $0.600600004/$4.48999977.

Recent News

chart

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)

The QualityStocks Daily Newsletter would like to spotlight Energy Fuels Inc. (UUUU).

Energy Fuels (NYSE American: UUUU) (TSX: EFR) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “On May 1, 2020, UUUU released its financial and operating results for Q1 2020. Based on these results and near-term production expectations, we believe UUUU is going to wait for improved uranium price before increasing production. Due to this and recent equity transactions, we are cutting our price target from $3.25 to $2.00 and maintaining our Buy rating.” To request access to the full report, visit http://nnw.fm/DXCr3

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), based in Lakewood, Colorado, is the country’s largest producer of uranium and the leading conventional producer of vanadium, both designated by the U.S. government as critical minerals.

As the leading U.S. diversified uranium miner, Energy Fuels’ uranium production portfolio stands apart in the world. Energy Fuels has more uranium production facilities, more production capacity, and more in-ground resources than any other company in the United States. In fact, the company’s assets have produced over one-third of all U.S. uranium over the past 15 years and is uniquely positioned to increase production to meet new demand.

Energy Fuels utilizes both conventional and in-situ recovery (“ISR”) technology to produce uranium from three strategic facilities:

  • White Mesa Mill in Utah (conventional) has a licensed capacity of over 8 million pounds of U3O8 per year. The highly strategic White Mesa Mill is the only conventional uranium mill in the country and is proximate to some of the largest and highest-grade uranium mines and projects in the U.S., including the Company’s Canyon mine, La Sal Complex, Henry Mountains Complex and Roca Honda Project. White Mesa Mill provides Energy Fuels with significant production scalability as uranium demand increases. The White Mesa Mill also has other diverse businesses, including vanadium, rare earth elements (REE’s), alternate feed materials recycling and land cleanup, all described below.
  • Nichols Ranch Plant (ISR) is located in the productive Powder River Basin district of Wyoming and has a total licensed capacity of 2 million pounds of U3O8 per year. Nichols Ranch has produced 1.2 million pounds of U3O8 since commissioning in 2014, and it has significant future expansion potential from 34 fully licensed wellfields containing significant in-ground uranium resources.
  • Alta Mesa Plant (ISR) is located on over 200,000 acres of private land in Texas. The fully licensed and constructed ISR project has a total operating capacity of 1.5 million pounds of uranium per year and produced nearly 5 million pounds of U3O8 between 2005 and 2013. This low-cost production facility is currently on standby, maintained in a state of readiness to respond to expected increases in demand.

In addition to being the largest uranium miner in the U.S., Energy Fuels’ overall portfolio also includes a pipeline of high-quality, large-scale exploration and development projects that are permitted or are in advanced stages of permitting, as well as an industry-leading U.S. NI 43-101 Mineral Resource portfolio.

FACTOID: Energy Fuels has led industry efforts over the past two-plus years to get the U.S. government to recognize the importance of domestically produced uranium, including the 2018 – 2019 Uranium Section 232, the ongoing Nuclear Fuel Working Group and the recently announced creation of the U.S. strategic uranium reserve. The U.S. is by far the largest consumer of uranium in the world, yet we import almost all of our requirements; Energy Fuels aims to change that.

Nuclear Market Potential

Multiple studies in top scientific journals have shown that nuclear power is cleanest and most economical way to produce reliable electricity as worldwide demand continues to soar. Nuclear power is presently the only available and affordable low-carbon power source that can meet both current and future baseload electricity demands while simultaneously reducing air pollution and mitigating climate change. U.S. nuclear power plants currently generate nearly 20% of the nation’s electricity overall and 55% of its carbon-free electricity and even a modest increase in electricity demand would require significant new nuclear capacity by 2025. According to the World Nuclear Association (WNA), there are currently 441 operable reactors, with another 54 units under construction and 439 in various stages of planning; in addition, the WNA has identified a potentially massive supply/demand gap through 2040 of 1 billion pounds. These factors among others are expected to significantly drive increased demand for uranium.

Reasons Nuclear is Gaining Traction

  • Nuclear reactors emit no greenhouse gases during operation. Over their full lifetimes, they result in comparable emissions to renewable forms of energy such as wind and solar.
  • Unlike any other form of energy, the waste from nuclear energy is contained and managed securely. Used fuel is currently being safely stored for ultimate disposal or future reprocessing, and 96% of this waste can potentially be recycled.
  • Greater demand for clean electricity to power everything from homes to automobiles, reducing dependence on fossil fuels.

No. 1 U.S. Producer of Vanadium in 2019

Energy Fuels also produces vanadium as a byproduct of uranium production. Vanadium is designated a critical mineral, essential to the economic and national security of the United States. Energy Fuels was the largest producer of vanadium in the U.S. in 2019, and has significant high-grade, in-ground vanadium resources, as well as a separate high-purity vanadium production circuit at their White Mesa Mill, which is also the only conventional vanadium mill in the country. Crucial for use in the steel, aerospace, and chemical industries, vanadium plays a critical role in the production of high-strength and light-weight metallic alloys and demand is expected to increase across the globe.

Energy Fuels has several fully permitted and developed standby mines containing large quantities of high-grade vanadium, along with uranium, including:

  • La Sal Complex (Utah)
  • Whirlwind Mine (Colorado/Utah)
  • Rim Mine (Colorado)

Vanadium has also gained increased attention as a catalyst in next-generation high-capacity, “community-scale” batteries used for energy storage generated from renewable sources. Demand is only expected to grow as this market expands. With recent upgrades in its vanadium production operations, in 2019 Energy Fuels produced commercial levels of the highest purity (99.7%) vanadium in the mill’s history and can rapidly adjust production to meet volatile market conditions. Energy Fuels is one of the very few known avenues that provides investors access the vanadium market.

Rare Earth Element (REE) Production, Alternate Feed Material Recycling, and Land Cleanup

The White Mesa Mill also provides the company with diverse cashflow generating opportunities. Security of supply for Rare Earth Elements (REEs) supporting U.S. military and defense requirements is a major issue today. Energy Fuels has been approached by a number of entities, including the U.S. government, inquiring about the potential to process certain REEs at the mill. The White Mesa Mill is currently licensed to process certain REEs, including tantalum and niobium. And, early indications are that the mill can be utilized to produce several other REEs. The White Mesa Mill is also the only facility in North America licensed and capable of recycling alternate feed materials (AFMs). AFMs are essentially low-level waste materials that contain recoverable quantities of natural (or unenriched) uranium. The Company typically generates between $5 and $15 million per year from AFM recycling. Finally, Energy Fuels is seeking to become involved in the cleanup of legacy Cold War era uranium mines in the Four Corners region of the U.S., including on the Navajo Nation. The U.S. Environmental Protection Agency (EPA) has access to over $1.5 billion for the cleanup of just a fraction of the sites on the Navajo Nation. The White Mesa Mill is fully licensed to receive much of this material, we are one of the government’s lowest cost options, and we have the ability to recycle the material and produce usable uranium from it.

Management Team

Mark S. Chalmers, President and CEO
Mark S. Chalmers is the president and chief executive officer of Energy Fuels, a position he has held since Feb. 1, 2018, following his role as chief operating officer of Energy Fuels from July 1, 2016 – Jan. 31, 2018. From 2011 to 2015, Chalmers served as executive general manager of Production for Paladin Energy Ltd., a uranium producer with assets in Australia and Africa, including the Langer Heinrich and Kayelekera mines where, as head of operations, he oversaw sustained, significant increases in production while reducing operating costs. He also possesses extensive experience in in situ recovery (“ISR”) uranium production, including management of the Beverley Uranium Mine owned by General Atomics (Australia), and the Highland mine owned by Cameco Corporation (USA). Chalmers has also consulted to several of the largest players in the uranium supply sector, including BHP Billiton, Rio Tinto, and Marubeni, and until recently served as the chair of the Australian Uranium Council, a position he held for 10 years. Chalmers is a registered professional engineer and holds a Bachelor of Science in Mining Engineering from the University of Arizona.

W. Paul Goranson, COO
W. Paul Goranson is the chief operating officer for Energy Fuels. Goranson has 30 years of mining, processing and regulatory experience in the uranium extraction industry that includes both conventional and in-situ recovery (“ISR”) mining, and he is a registered professional engineer. Prior to the acquisition by Energy Fuels of Uranerz Energy Corporation, Goranson served as president, chief operating officer and director for Uranerz, where he was responsible for operations of the Nichols Ranch ISR Uranium Project. In addition to those duties, he also managed uranium marketing, regulatory and government affairs, exploration and land. Prior to joining Uranerz, Goranson served as president of Cameco Resources, where he led the operations at the Smith Ranch-Highland, Crow Butte and North Butte ISR uranium recovery facilities. Goranson also served as vice president of Mesteña Uranium LLC, and he has served in senior positions with Rio Algom Mining, (a subsidiary of BHP Billiton), and Uranium Resource Inc. Goranson has a Bachelor of Science in Natural Gas Engineering from Texas A&I University, and a Master of Science in Environmental Engineering from Texas A&M University-Kingsville.

David C. Frydenlund, CFO, General Counsel, Corporate Secretary
David C. Frydenlund is chief financial officer, general counsel, and corporate secretary of Energy Fuels. His responsibilities include oversight of all legal matters relating to the company’s activities. His expertise extends to NRC, EPA, state and federal regulatory and environmental laws and regulations. From 1997 to 2012, Frydenlund was vice president of regulatory affairs, general counsel and corporate secretary of Denison Mines Corp., and its predecessor International Uranium Corporation (“IUC”). He also served as a director of IUC from 1997 to 2006 and CFO of IUC from 2000 to 2005. From 1996 to 1997, Frydenlund was vice president of the Lundin Group of international public mining and oil and gas companies, and prior thereto was a partner with the Vancouver law firm of Ladner Downs (now Borden Ladner Gervais) where his practice focused on corporate, securities and international mining transactions law. Frydenlund holds a bachelor’s degree in business and economics from Simon Fraser University, a master’s degree in economics and finance from the University of Chicago and a law degree from the University of Toronto.

Curtis H. Moore, Vice President of Marketing and Corporate Development
Curtis H. Moore is the vice president of Marketing and Corporate Development for Energy Fuels. He oversees product marketing for Energy Fuels, and is closely involved in mergers & acquisitions, investor relations, public relations, and corporate legal. He has been with Energy Fuels for over 12 years, holding various roles of increasing responsibility. Prior to joining Energy Fuels, Moore worked in multi-family real estate development, government relations and public affairs, production homebuilding, and private law practice. Moore is a licensed attorney in the State of Colorado. He holds Juris Doctor and MBA degrees from the University of Colorado at Boulder, and a Bachelor of Arts dual degree in Economics-Government from Claremont McKenna College in Claremont, California.

 

Energy Fuels Inc. (UUUU), closed Tuesday's trading session at $1.74, up 2.9586%, on 1,700,974 volume. The average volume for the last 3 months is 1,830,895 and the stock's 52-week low/high is $0.779999971/$3.31999993.

Recent News

chart

National Storm Recovery Inc. (OTC: NSRI)

The QualityStocks Daily Newsletter would like to spotlight National Storm Recovery Inc. (NSRI).

National Storm Recovery Inc. (OTC: NSRI), a leading provider of environmentally beneficial solutions to tree and storm waste disposal, today announced a $20,503,975 valuation of its February 10, 2020 Mulch Manufacturing acquisition equipment assets through a third-party certified appraisal. This valuation strictly includes the production equipment located within different locations, as detailed in the update. To view the full press release, visit http://nnw.fm/7IIks. The waste management market consists of collecting, transporting, disposing, recycling, and monitoring of waste items. Also today, the company was highlighted in a publication from Financialnewsmedia.com, examining how the solid waste management market is set to cross USD $1.2 Trillion by 2026, as reported in the latest study by Global Market Insights, Inc. According to the report, the market is anticipated to witness robust growth on account of strong focus of respective government to cater the various environmental issues. Large scale urban migration has exponentially increased the waste generation statistics across cities.

National Storm Recovery Inc. (OTC: NSRI), through its subsidiaries, including National Storm Recovery, LLC (DBA Central Florida Arbor Care and Mulch Manufacturing, Inc.), provides tree services, debris hauling, removal and bio-mass recycling, manufacturing, packaging and sales of next-generation mulch products. The company’s primary corporate objective is to provide a solution for the treatment and handling of tree debris that is historically sent to local landfills and disposal sites, creating an environmental burden and pressure on disposal sites around the nation.

Environmentally Friendly

National Storm and the solutions provided by its Sustainable Green Team are founded in sustainability. The company’s vertically integrated operations begin with the collection of tree debris through its tree services division and collection sites. Tree bio-mass is then moved through the processing division for recycling and manufacturing into a variety of organic, attractive, next-generation mulch products to be packaged and sold to retailers, landscapers, installers and garden centers.

The company’s solutions create a synergistic and environmentally beneficial solution to tree and storm waste disposal that historically has created an environmental burden on landfills and disposal sites around the nation.

National Storm’s customers include governmental, residential and commercial customers and now big box retailers. The company is headquartered in Florida.

Strategic Acquisition

National Storm in February 2020 acquired 35-year-old industry leader and innovator Mulch Manufacturing, Inc., an Ohio corporation. Structured as a share exchange, this strategic partnership provides National Storm with a significantly larger footprint in the mulch industry.

The acquisition includes Mulch Manufacturing’s national and international distribution agreements, an increase in production and packaging capacity, and its sales contracts with numerous big box retailers. Mulch Manufacturing includes mulch production, sawmill operation, Natures Reflections colorant manufacturing and equipment manufacturing.

Next-Gen Products

National Storm’s vision and commitment to the environment is paired with Mulch Manufacturing’s revolutionary “next-generation” mulch product, Nature’s Reflection’s Softscape®.

Softscape mulch products, created from natural forest products, are color-enhanced with environmentally safe colorants to provide four-year color retention and are free from contaminants. Safe for people and pets, Softscape allows water and air to penetrate soil and roots, which is vital to plant health and growth.

Expansion Plans

National Storm plans to expand its operations through a combination of organic growth, through its partnership with a nationally recognized waste disposal company, and through strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified.

The company has received final zoning approval for its 100-acre site, located in Lake County, Astatula, Florida, which will serve as the company’s flagship tree debris collection site. The facility will also house the company’s mulch manufacturing, soil composting and production bagging. This prime location includes a 5,000-square-foot building that contains warehouse and office space. The 100-acre property can accommodate millions of cubic yards of organic debris and will allow National Storm’s debris hauling division to realize significant savings on its transportation costs.

National Storm has chosen as its new headquarters the Mulch Manufacturing 100,000-square-foot building in Jacksonville, Florida. The facility comprises centralized operations of Mulch Manufacturing, Inc. and National Storm Recovery, LLC, and has ample room to expand as the needed.

Leadership

National Storm’s Sustainable Green Team boasts more than 40 years of next-level experience with mulch manufacturing, treating and caring for trees. This team is guided by a roster of highly qualified professionals:

  • Tony Raynor, Chief Executive Officer
  • Edward Lee, Chief Operating Officer
  • Ralph Spencer, Director of Business Development, Strategic Acquisitions
  • Steve Ogden, ISA-Certified Arborist
  • Rick Starcher, Master Chemist
  • Peder K. Davisson, Esq., Corporate/Securities Counsel

National Storm Recovery Inc. (OTC: NSRI), closed Tuesday's trading session at $0.79, up 33.8983%, on 3,580 volume with 10 trades. The average volume for the last 3 months is 849 and the stock's 52-week low/high is $0.05/$3.00.

Recent News

chart

Champignon Brands Inc. (FWB: 496) (CSE: SHRM) (OTC: SHRMF)

The QualityStocks Daily Newsletter would like to spotlight Champignon Brands Inc. (CSE: SHRM).

Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a research-driven company specializing in the formulation and distribution of a suite of artisanal mushroom health supplements, will be the headline partner for Prohibition Partners LIVE’s PSYCH: The Psychedelics Symposium (PSYCH) (http://cnw.fm/Bg9s5). Slated for June 22-23, 2020, this Prohibition Partners LIVE event brings together health care, science and business leaders from around the world to discuss new findings in the cannabis and psychedelic space.

Champignon Brands Inc. (FWB: 496) (CSE: SHRM) (OTC: SHRMF) is a research-driven company specializing in the formulation and distribution of a suite of artisanal mushroom health supplements. Dedicated to revolutionizing conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, Champignon’s expanding portfolio is crafted with the health-conscious consumer in mind.

Headquartered in Vancouver, British Columbia, Champignon’s team aims to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health care and pharmaceutical products.

Brands

Champignon’s mushroom-derived consumer packaged goods (CPGs) portfolio includes its flagship brand, Vitality Superteas. Each carefully curated Vitality Supertea formulation was developed with the intent of helping individuals enhance and enrich their wellbeing one cup of mushroom-infused tea at a time.

Also in the portfolio are Nourish Force Supertea, a blend of Reishi Ryobus Tea Mix; Mighty Recharge Supertea, created with Lions Mane Tropical Green Ginseng Tea Mix; and Brain Enhance Supertea, a blend of Cordycep Hibiscus and Berries Tea Mix – all of which are formulated with organic ingredients and chosen for their ability to provide unique health and performance benefits.

Champignon’s flagship e-commerce store, VitalitySuperTeas.com, takes advantage of the burgeoning craft mushroom vertical space with a selection of mushroom-infused teas and accessories.

Functional Mushroom Market

Demand for consumer products infused with the nutritional and bioactive benefits of mushrooms is fueling a global market projected to reach $34.3 billion by 2024, growing at a compound annual growth rate of 8.04% from 2019-2024 (ResearchandMarkets), with Europe seen as the fastest growth leader.

According to the market study, in highest demand are products infused with Reishi – a traditional Chinese medicine also known as the “Elixer of Life” and “Mushroom of Immortality – Lions Mane and Cordyceps, followed by other types of medicinal mushrooms.

Advances in Legalization

Legalization of psychedelics for use in medicine is gaining momentum across the United States. Denver, Colorado, and Oakland and Santa Cruz, California, have decriminalized the use of psilocybin, the psychedelic molecule found in various mushrooms, while movements for legalization are gaining ground in Oregon and Iowa, among others. Decriminalize California recently teamed up with the Beckley Foundation to replicate Oakland’s success of decriminalization throughout the state of California.

An increasing number of researchers are turning their attention toward the study of psilocybin as a means to treat otherwise untreatable illnesses. The molecule’s ability to provide landmark treatment options for depression, post-traumatic stress disorder (PTSD), migraines and addiction is gaining widespread acceptance among medical professionals, unicorn investors and accredited institutions.

Potential Applications

Historical data and new scientific studies suggest therapeutic benefits of psychedelics in many areas, including drug addiction, alcoholism, depression, migraines, smoking cessation and post-traumatic stress disorder (PTSD).

The market potential in these areas are significant. To reference just one of the above conditions, the mental health arena has been frequently neglected over the last 30 years, though new research is beginning to further reinforce that psychedelic compounds have the potential to produce more effective treatments than what is currently available.

According to the World Health Organization, 25% of the world’s populous will be afflicted by mental health and/or neurological disorders. Presently, approximately 450 million people currently suffer from such conditions, placing mental disorders among the leading causes of ill-health, productive loss and disability worldwide.

Additionally, PTSD affects approximately 2.2% of the U.S. population; 7.7 million people will have PTSD at some point in their lives. Recent published studies have demonstrated the safety and efficacy of certain psychedelics when administered in a medically supervised and monitored approach.
A renaissance in alternative medicines is emerging, and Champignon has set in motion its strategy to become a key player.

2020 Stealth IP Strategy

Champignon plans to biosynthesize psilocybin within the first three months of conducting laboratory experiments, with the objective of achieving optimized and scaled production of pharmaceutical-grade psilocybin for deployment in clinical settings. This strategy includes:

  • Alternative medicine (psilocybin) IP aggregation
  • Development of cGMP formulations of bioactive compounds extracted from plants and Fungi
  • Drafting of benchmark SOPs (Standard Operating Procedures)
  • Patient aggregation, focusing on veterans

Defining a New Asset Class: Psychedelic-Inspired Medicines

In the third quarter of 2020, Champignon – through clinical trials, a compelling IP portfolio and clinical pipeline and drug development platform – plans to advance its pursuit of treatments underpinned by psychedelic substances. This strategy is broken down into two ties:

  • Non-Hallucinogenic Medicines
    • Microdosing Psilocybin/LSD
    • MDMA, commonly known as ecstasy
  • Hallucinogenic Medicines
    • Psilocybin high dose
    • LSD high dose

Partnerships

Companies worldwide are beginning to incorporate functional mushrooms into their product offerings, taking advantage of growing consumer awareness of known health benefits of the ingredients found in mushrooms.

Champignon in November 2019 entered into a distribution partnership with Eurolife Brands Inc. (CSE: EURO), a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide through a data-driven CBD marketplace supported by exclusive and unbiased physician-backed cannabis education and detailed consumer analytics. Under the agreement, Champignon’s branded products are integrated into Eurolife’s e-commerce platform, along with potential distribution opportunities in select brick-and-mortar retail locations in Europe.

Champignon also has an R&D/production formulation agreement with Drip Coffee Social Ltd., located in Nanaimo, British Columbia, which calls for the infusion of Champignon’s proprietary mushroom extract blend into a suite of cold brew coffee products and signature in-house formulations.

Leadership

Gareth Birdsall, CEO, Corporate Secretary and Director
Gareth Birdsall has more than seven years of experience working in diverse agricultural roles such as the cultivation of various fungi, in particular Cordycepes, Reishi, Lions Mane and Chaga. He is an attendee of the British Columbia Institute of Technology, studying marketing management and finance.

Steven Brohman, CPA, CFO
Steven Brohman has more than 10 years of experience working in a variety of roles with public and private companies. He has had extensive training in the audit of publicly traded companies on the TXS, TSX Venture Exchange and OTC markets, and serves as CFO and director of various public and private companies. Brohman has a bachelor’s degree of business administration and obtained his Chartered Professional Accountant designation.

Jerry Habuda, Director
Jerry Habuda brings to Champignon over 35 years of expertise in law enforcement and specialized units. From 1977 to 2012, he served as a police officer with the Toronto Police Department. During his tenure, he was assigned to the Major Crimes Unit, investigating robberies and home invasions. He was assigned to patrol the Toronto Community Housing projects at Jane/Finch to control drug trafficking and gun violence. Habuda was with the Warrant Unit where he tracked down and arrested wanted criminals. From 1993-1997, he was assigned to the Northwest Drug Squad on undercover and surveillance work, executing narcotic search warrants. Between 2002 and 2004, Habuda headed the Street Violence Task Force, a special unit designed to curb gun and drug violence that was terrorizing the city at the time.

Champignon Brands Inc. (CSE: SHRMF), closed Tuesday's trading session at $0.76, up 1.3333%, on 638,713 volume with 776 trades. The average volume for the last 3 months is 179,025 and the stock's 52-week low/high is $0.221/$0.998300015.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint (OTCQB: SING) announced today that it is starting its second quarter with strong numbers and the focus on continued growth. According to the update, SinglePoint’s Hemp vertical is on track to double sales in Q2 alongside the launch of 1606 Hemp six-pack counter top display. 1606 Hemp has seen a 133% increase in sales growth this quarter, as well as a 233% growth in sales up to this point of the month compared to the same timeframe in the previous month.  SinglePoint has placed a focus on self-generated in store placement by hiring professional sales representatives to acquire new stores for the sales of its products over the next four weeks. The company’s goal is to grow 1606 by more than 250 retail accounts throughout multiple states. To view the full press release, visit http://cnw.fm/9EwBm. Also today, the company was featured in news regarding the BOX BioScience joint venture with Singlepoint (OTC: SING) to distribute hand sanitizer products manufactured out of Carlsbad, CA.  The companies are distributing FDA approved hand sanitizer products principally on the East and West coast.  BOX has distribution centers in Carlsbad, CA, Raleigh, NC, and its home office is located in Charleston, SC.  Coronavirus (Covid-19) has placed a premium and created a shortage of hand sanitizer and disinfectant products.  Additionally, SING was was featured in today's edition of the Investorideas.com potcastsCM http://ibn.fm/NfYsl

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Tuesday's trading session at $0.005365, up 3.1731%, on 6,713,068 volume with 132 trades. The average volume for the last 3 months is 5,960,491 and the stock's 52-week low/high is $0.004/$0.021999999.

Recent News

chart

Trxade Group Inc. (NASDAQ: MEDS)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (NASDAQ: MEDS).

Trxade Group Inc. (NASDAQ: MEDS) was featured in a recent equity research report published by Dougherty & Company LLC. The report reads, “We reiterate our Buy rating and $12 Price Target on MEDS following Q1 results that beat expectations. As the only estimate on the Street, we note that revenue, EBITDA and EPS were each ahead of our forecast. MEDS added 305 new pharmacy registrations which was in line with our forecast of 300. To request access to the full report, visit http://nnw.fm/JXH6i

Trxade Group Inc. (NASDAQ: MEDS) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade’s overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company’s pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, “E-Bay/Kayak-like” technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the “consumer side” of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called “Delivmeds” (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade’s Managed Services Organization (“TrxadeMSO”) enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient’s information, thereby ensuring appropriate medication coverage based on the patient’s location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade’s fair online market platform targets the nation’s retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE’s programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.  
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks (“PAC”) to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry. 
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE’s advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process. 

Management Team 

Trxade’s management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade’s chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade’s full-time president and COO, and as a director since the company’s acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (MEDS), closed Tuesday's trading session at $7.36, off by 2.9664%, on 47,650 volume. The average volume for the last 3 months is 127,188 and the stock's 52-week low/high is $2.70000004/$11.6000003.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Elepreneurs LLC, an operating subsidiary of Sharing Services Global Corporation (OTCQB: SHRG), held its first virtual live convention. Dubbed the Happiness Revolution, the April 25-26 event was designed to support, encourage and empower SHRG’s network of independent representatives called Elepreneurs. The two-day event attracted more than 3,000 participants, offering these aspiring home entrepreneurs the opportunity to network and meet field leaders and the corporate team (http://nnw.fm/7Ks3s). Also today, the Company commented on Monday’s announcement of the appointment of Chan Heng Fai Ambrose to serve on its board of directors (the “Board”) as a Class II Director to serve until the annual meeting of shareholders in 2023, or until his successor is elected and qualified. According to the update, the appointment fills a vacancy created by the recently announced resignation of Kip H. Allison from the Board. To view the full press release, visit http://nnw.fm/F9lF8

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

Contact
469.304.9400 x 201
Info@SHRGinc.com
http://www.SHRGinc.com

Sharing Services Global Corporation (SHRG), closed Tuesday's trading session at $0.075, off by 10.7143%, on 5,000 volume with 1 trade. The average volume for the last 3 months is 710,797 and the stock's 52-week low/high is $0.0215/$0.249799996.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that it has entered into a patent and technology license agreement with The University of Texas MD Anderson Cancer Center, granting Genprex an exclusive worldwide license to a portfolio of 16 patent applications and related technology (“Licensed IP”) for the treatment of cancer using Genprex’s lead drug candidate and TUSC2 gene therapy, known as “Oncoprex” or “GEN-001,” in combination with immunotherapies. To view the full press release, visit http://nnw.fm/Cf8NI. Also today, the company was highlighted in a publication from Financialnewsmedia.com, examining how the global market for cancer therapies is projected to reach US$220. 5 billion by 2025, driven by the rise in cancer prevalence to epidemic proportions and the still ongoing search to find effective treatments for the disease.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Tuesday's trading session at $3.50, up 51.5152%, on 60,681,686 volume. The average volume for the last 3 months is 6,573,756 and the stock's 52-week low/high is $0.231000006/$7.0300002.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) was featured in today's edition of the Investorideas.com potcastsCM http://ibn.fm/yaKAY.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (CNPOF), closed Tuesday's trading session at $0.5838, off by 1.3018%, on 58,630 volume with 76 trades. The average volume for the last 3 months is 99,810 and the stock's 52-week low/high is $0.371499985/$3.52999997.

Recent News

chart

Cannabis Global, Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Global, Inc. (MCTC).

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced its entry into a definitive, five-year agreement (the "Agreement") for the production of cannabis edibles and beverages in conjunction with licensed California cannabis operator, Magnolia Extracts, LLC of Lynwood, California. Under the Agreement, Cannabis Global will provide access to its trade secrets and patent pending technologies for chemical-free cannabis and hemp infusions in the production of edibles and beverages containing tetrahydrocannabinol (“THC”). To view the full press release, visit http://cnw.fm/N8jSa.

Cannabis Global, Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

Cannabis Global, Inc. (MCTC), closed Tuesday's trading session at $0.2125, off by 7.6087%, on 190,303 volume with 73 trades. The average volume for the last 3 months is 14,428 and the stock's 52-week low/high is $0.05/$3.00.

Recent News

chart

Cannabis Strategic Ventures, Inc. (OTCQB: NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (OTCQB: NUGS).

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today announced that the company achieved record sales during the last week of April. The company reported a significant increase in sales for the month of April, with numbers climbing more than 800% higher than the average monthly totals seen in calendar Q1. NUGS recently doubled its production capacity, enabling the company to continue to take on growing distributor relationships and larger orders in the California cannabis market. To view the full press release, visit http://cnw.fm/jXzJ9

Cannabis Strategic Ventures, Inc. (OTCQB: NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (OTCQB: NUGS), closed Tuesday's trading session at $0.0862, off by 7.3118%, on 1,665,198 volume with 234 trades. The average volume for the last 3 months is 1,115,320 and the stock's 52-week low/high is $0.025499999/$1.29999995.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc (GGBXF) was featured today in the 420 with CNW by CannabisNewsWire. With the coronavirus outbreak ravaging most continents, we’ve been forced to find ways to keep crucial services running. The internet has played an integral role, especially in regard to meetings, learning, and shopping. One other crucial contribution has been telehealth.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed Tuesday's trading session at $0.04, off by 5.8824%, on 440,298 volume with 114 trades. The average volume for the last 3 months is 966,509 and the stock's 52-week low/high is $0.035/$4.48999977.

Recent News

chart

The Movie Studio Inc. (OTC: MVES)

The QualityStocks Daily Newsletter would like to spotlight The Movie Studio Inc. (OTC: MVES).

The Movie Studio Inc. (OTC: MVES) is a vertically integrated motion picture production company focused on acquiring, developing, producing and distributing independent motion picture content for worldwide consumption via subscription and advertiser video on demand (SVOD/AVOD), over the top (OTT) platforms, foreign sales and various media devices. The company is currently engaged in establishing its own OTT VOD platform to integrate both its own and aggregated feature film projects, television programming and other media intellectual properties. The Movie Studio is disrupting traditional media content delivery systems with its digital business model of motion picture distribution, and the company intends to create a direct server access platform of its content with geo-fractured territories for worldwide distribution.

The company has launched The Movie Studio App on Google Play and the App Store, enabling users to both view the company’s content and potentially become part of it. The app is in the completion stage, and The Movie Studio is conducting its final beta test of the app’s unique “audition submission” function, leveraging the company’s “Watch Our Movies, Be in Our Movies!” content platform and “Everyone’s a Star” campaign, which will be marketed via social media. Using the app, subscribers can upload a thumbnail photo of themselves along with a selfie video audition submission that showcases them reading character dialog. Audition submissions will then be reviewed by producers for possible participation of the auditionee in upcoming feature films.

The audition submission function provides the subscriber the ability to disrupt traditional motion picture casting and management, enabling access to participation in The Movie Studio’s independent motion picture and media content. At the same time, for the company this significantly reduces capital expenditures associated with those traditional media mechanisms. The Movie Studio’s unique business model capitalizes on the global demand for film content through the production and distribution of its own films while also providing opportunities for direct viewer involvement in its content.

The company operates using a growth-by-acquisition strategy that includes:

  • Purchasing legacy film libraries.
  • Upgrading acquired films to 4K resolution and remonetizing with “new” film content on popular VOD streaming platforms across the internet.
  • Strategic partnerships and media content alignment with other OTT platforms and cross-collateralization of leverageable media assets for worldwide distribution.
  • Producing micro-budget motion picture content with substantial production value utilizing new 4K technology and the company’s extensive legacy resources and unique production process, thereby significantly reducing capital expenditures while allowing for the potential of significant return on investment (ROI) with one successful production.
  • Controlling its revenue streams through server-driven geo-fracturing global territories and its own OTT platform.

Currently, The Movie Studio is producing three upcoming feature films: “Cause and Effect,” “The Last Warhead” and “PEGASUS” — all with completed electronic press kits and pitch decks and fully produced motion picture-quality trailers ready for talent, distribution and financial integration.

The company has been successful in producing, casting and distributing its films on major SVOD platforms without recognizable stars, which reduces capital expenditures. However, The Movie Studio intends to integrate recognizable stars into the productions at value propositions either pre- or post-completion of the intellectual property.

Through successful beta testing, The Movie Studio has monetized film assets on the Amazon, tubi tv, Comcast and Showtime platforms.

The company’s proposed server-based model will provide licensing payment from global territories without third-party distribution fees, which have traditionally been as high as 35%.

Founded in 1961 and formerly known as Destination Television, Inc., the company changed its name to The Movie Studio, Inc. in November 2012. The Movie Studio is headquartered in Fort Lauderdale, Florida.

Cord-Cutting Creates Opportunity for VOD Players

Consumers are no longer content waiting for their favorite programming to come on the air – they expect instant streaming access where and how they want it. This has led to increased “cord cutting,” with consumers severing ties with their traditional pay TV providers in favor of digital streaming services.

With the advent of smart TVs with app integration, consumers can now watch what they want to watch when they want to watch it, fracturing traditional cable bundling mechanisms.

With pay TV usage steadily declining – satellite and cable TV businesses in the United States lost approximately 6 million customers in 2019 alone – streaming platforms are poised to potentially replace traditional pay TV distribution models altogether. Approximately 12,000 U.S. consumers are cutting the cord every day.

As this shift in media delivery continues and as digital devices become more sophisticated and bandwidth increases, VOD platforms have the potential to scale significantly. The Hollywood “streaming wars” of recent years have created an environment in which smaller competitors, like The Movie Studio, are able to emerge as major brands.

The Movie Studio Inc. (OTC: MVES), closed Tuesday's trading session at $0.0129, up 17.8082%, on 380,513 volume with 9 trades. The average volume for the last 3 months is 62,024 and the stock's 52-week low/high is $0.0063/$0.07.

Recent News

chart

PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA)

The QualityStocks Daily Newsletter would like to spotlight PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA).

A Better Way to Connect and Acquire Vehicles

PowerBand’s mission is to create an online, consumer-directed marketplace that streamlines the interactions among all participants in the automotive industry. It transforms today’s antiquated business model with speed, transparency, access to information and ease of use for consumers and dealers.

Consumers can easily connect with new sources to buy vehicles, network with motivated buyers and sellers, maximize their trade-in values, improve their customer experience. PowerBand’s standardized system and transaction process also increase efficiencies and benefits with hands-on, process-driven, in-store training and support.

Through internal development, acquisitions, joint ventures and strategic partnerships, PowerBand is developing solutions for consumers, dealers, manufacturers, commercial customers and lenders that are poised to transform the trillion-dollar U.S. automotive industry.

The PowerBand Auto Platform

PowerBand’s transaction platform was developed by a team of experienced automotive, technology and finance experts, and has been refined through years of operational experience. Built on the core belief that the consumer prefers to primarily conduct automotive transactions online and avoid interactions with unnecessary middlemen, PowerBand’s product solutions include:

  • Leasing: PowerBand is currently licensed in 33 U.S. states via a majority interest in MUSA Auto Finance LLC, an advanced online leasing technology platform that has transformed the new and used vehicle leasing industry. A partnership with Tesla was recently finalized, making MUSA the only approved, non-captive lease partner for Tesla in the U.S.
  • Inventory and Financing: A partnership with RouteOne LLC, a leading financial platform founded in 2002 by Ally Financial, Ford Motor Credit Co., TD Auto Finance and Toyota Financial Services, allows access to a network of more than 18,000 dealerships and 1,400 financing sources.
  • Auction Platform: PowerBand and its joint-venture partner, D2D Auto Auctions, are developing a direct consumer-to-dealer and a consumer-to-consumer automotive portal, which will provide an innovative alternative to physical dealership and auction locations.
  • LiveNet Auction: An online platform portal that allows dealers to create instant live vehicle auctions to a vast network of the industry’s top used vehicle buyers.
  • MarketPlace Auction: An online listing auction site for buying and selling automotive inventory – ideal for dealers, fleet, OEM and rental companies.
  • Used Vehicle Inspections: An LOI agreement with TÜV NORD Mobility Inc., a German-based global leader in vehicle inspections operating in more than 70 countries, will provide the most comprehensive, certified vehicle inspection reports available in North America. Appointments booked within the platform can be performed nearly anywhere.
  • Product Development: PowerBand’s comprehensive consumer solution, Driveaway, will be a fully transactional consumer marketplace where dealers and consumers can buy, sell, trade-in and finance vehicles, often in seconds, from the comfort of their home.

Automotive’s Growing Markets

The automotive dealership and commercial fleet vehicle auction industry is a $100-billion sector with more than 40 million used vehicles transacted in the U.S. each year. Of those, ten million are sold through auctions. From 2013 to 2017, the growth of online-only auctions far outpaced physical auctions, growing at a 33% compound annual growth rate compared to 2% CAGR at physical auctions.

Automotive leasing is another large, growing and fragmented market, generating approximately $120-billion in annual revenue. As a percentage of vehicle sales, leasing reached 30% in 2018, up from 21% in 2012, and is seen as a substantial opportunity for PowerBand and MUSA Auto Finance. Using proprietary technology and by focusing on high-quality, credit-worthy customers, MUSA grew its automotive lease originations to $182 million.

Disrupting Auto Leasing with MUSA

Legacy solutions are complicated, expensive and slow at processing leases. MUSA’s first-of-its-kind technology platform eliminates third-party decisions and the human capital required in the underwriting process. MUSA’s platform navigates the entire customer experience – underwriting, funding and the delivery process – within minutes. Leases can be approved in seconds.

PowerBand’s acquisition of MUSA brings together two leading-edge companies with the vision to become a one-stop platform for the entire vehicle purchase lifecycle.

Experienced Leadership

PowerBand is led by a collection of automotive veterans with a passion to collectively and positively impact the industry.

  • Kelly Jennings, president and CEO, is the founder of PowerBand Solutions and a franchise dealer owner/operator with more than 27 years of automotive experience. Jennings received General Motor’s Triple Crown Award, Ford Motor Company President’s Award and Honda Canada’s Excellence Award.
  • Darrin Swenson, COO of PowerBand and D2D Auto Auctions/Hunt Automotive Group, has more than 25 years of automotive/auction experience.
  • Jeff Morgan, CEO MUSA, holds over 25 years of experience in the auto finance sector.

 

PowerBand Solutions Inc. (OTCQB: PWWBF), closed Tuesday's trading session at $0.1087, up 10.4675%, on 3,500 volume with 4 trades. The average volume for the last 3 months is 27,669 and the stock's 52-week low/high is $0.038600001/$0.230000004.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.